Cite
MLA Citation
Elizabeth M. Rosenthal et al.. “Corrigendum to "Assessing the cost-utility of preferentially administering Heplisav-B vaccine to certain populations" [Vaccine 38(51) (2020) 8206–8215].” Vaccine, vol. 39, no. 36, 2021, pp. 5231–. http://access.bl.uk/ark:/81055/vdc_100139917135.0x000048